Advertisement
BIO vs CNP
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIO is a Buy and CNP is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BIO’s FA Score shows that 0 FA rating(s) are green whileCNP’s FA Score has 3 green FA rating(s).
- BIO’s FA Score: 0 green, 5 red.
- CNP’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BIO’s TA Score shows that 3 TA indicator(s) are bullish while CNP’s TA Score has 5 bullish TA indicator(s).
- BIO’s TA Score: 3 bullish, 5 bearish.
- CNP’s TA Score: 5 bullish, 5 bearish.
Price Growth
BIO (@Medical Specialties) experienced а -7.67% price change this week, while CNP (@Electric Utilities) price change was +2.59% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -2.60%. For the same industry, the average monthly price growth was -2.18%, and the average quarterly price growth was -4.69%.
The average weekly price growth across all stocks in the @Electric Utilities industry was -0.49%. For the same industry, the average monthly price growth was +0.50%, and the average quarterly price growth was +10.87%.
Reported Earning Dates
BIO is expected to report earnings on Oct 23, 2025.
CNP is expected to report earnings on Oct 29, 2025.
Industries' Descriptions
@Medical Specialties (-2.60% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Electric Utilities (-0.49% weekly)Electric utilities companies generate, transmit and distribute electricity to businesses/offices and residences. Companies may be owned by the government or investors or public shareholders, or a combination thereof. The industry also includes firms that buy and sell electricity. Companies in this industry typically require significant investments in infrastructure. Many firms in this industry pay substantial and regular dividends to shareholders. However, changes in interest rates (and their impact on debt burdens), natural disasters and changing commodity prices could be factors affecting energy utilities’ profit margins. NextEra Energy, Inc., Duke Energy Corporation, Dominion Energy Inc. and Southern Company are among U.S. electric utilities companies with the largest market capitalizations.
| BIO | CNP | BIO / CNP | |
| Capitalization | 9.79B | 18B | 54% |
| EBITDA | -654.76M | 3.19B | -21% |
| Gain YTD | -13.366 | 23.853 | -56% |
| P/E Ratio | 3.64 | 20.74 | 18% |
| Revenue | 2.67B | 8.7B | 31% |
| Total Cash | 1.61B | 631M | 255% |
| Total Debt | 1.41B | 18.6B | 8% |
BIO | CNP | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 65 | 18 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 81 Overvalued | 70 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 8 | |
SMR RATING 1..100 | 94 | 71 | |
PRICE GROWTH RATING 1..100 | 62 | 25 | |
P/E GROWTH RATING 1..100 | 82 | 14 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CNP's Valuation (70) in the Electric Utilities industry is in the same range as BIO (81) in the Medical Specialties industry. This means that CNP’s stock grew similarly to BIO’s over the last 12 months.
CNP's Profit vs Risk Rating (8) in the Electric Utilities industry is significantly better than the same rating for BIO (100) in the Medical Specialties industry. This means that CNP’s stock grew significantly faster than BIO’s over the last 12 months.
CNP's SMR Rating (71) in the Electric Utilities industry is in the same range as BIO (94) in the Medical Specialties industry. This means that CNP’s stock grew similarly to BIO’s over the last 12 months.
CNP's Price Growth Rating (25) in the Electric Utilities industry is somewhat better than the same rating for BIO (62) in the Medical Specialties industry. This means that CNP’s stock grew somewhat faster than BIO’s over the last 12 months.
CNP's P/E Growth Rating (14) in the Electric Utilities industry is significantly better than the same rating for BIO (82) in the Medical Specialties industry. This means that CNP’s stock grew significantly faster than BIO’s over the last 12 months.
| BIO | CNP | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 63% | 2 days ago 52% |
| Stochastic ODDS (%) | 2 days ago 73% | 2 days ago 37% |
| Momentum ODDS (%) | 2 days ago 66% | 2 days ago 56% |
| MACD ODDS (%) | 2 days ago 65% | 2 days ago 57% |
| TrendWeek ODDS (%) | 2 days ago 65% | 2 days ago 60% |
| TrendMonth ODDS (%) | 2 days ago 69% | 2 days ago 56% |
| Advances ODDS (%) | 8 days ago 67% | 2 days ago 55% |
| Declines ODDS (%) | 2 days ago 67% | about 1 month ago 42% |
| BollingerBands ODDS (%) | N/A | 2 days ago 33% |
| Aroon ODDS (%) | 2 days ago 62% | 2 days ago 48% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FSAEX | 13.63 | N/A | N/A |
| Fidelity Series All-Sector Equity | |||
| DRESX | 23.89 | N/A | N/A |
| Driehaus Emerging Markets Small Cap Gr | |||
| WFTIX | 13.73 | N/A | N/A |
| Allspring Innovation Fund - Class Inst | |||
| CFCYX | 14.24 | N/A | N/A |
| Columbia Flexible Capital Income Inst3 | |||
| AMBFX | 36.73 | -0.26 | -0.70% |
| American Funds American Balanced F2 | |||
BIO and
Correlation & Price change
A.I.dvisor indicates that over the last year, BIO has been closely correlated with A. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if BIO jumps, then A could also see price increases.
CNP and
Correlation & Price change
A.I.dvisor indicates that over the last year, CNP has been closely correlated with BKH. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if CNP jumps, then BKH could also see price increases.